Cargando…

Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach

Eosinophilic esophagitis (EoE) is a unique form of non-immunoglobulin E-mediated food allergy, restricted to the esophagus, characterized by esophageal eosinophil-predominant inflammation and dysfunction. The diagnosis requires an esophago-gastroduodenoscopy with esophageal biopsies demonstrating ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Visaggi, Pierfrancesco, Mariani, Lucia, Pardi, Veronica, Rosi, Emma Maria, Pugno, Camilla, Bellini, Massimo, Zingone, Fabiana, Ghisa, Matteo, Marabotto, Elisa, Giannini, Edoardo G., Savarino, Vincenzo, Marchi, Santino, Savarino, Edoardo V., de Bortoli, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151361/ https://www.ncbi.nlm.nih.gov/pubmed/34066243 http://dx.doi.org/10.3390/nu13051630

Ejemplares similares

Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
por: Visaggi, Pierfrancesco, et al.
Publicado: (2023)

Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak
por: Savarino, Edoardo, et al.
Publicado: (2020)

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
por: Marabotto, Elisa, et al.
Publicado: (2020)

The Lyon Consensus: Does It Differ From the Previous Ones?
por: Ghisa, Matteo, et al.
Publicado: (2020)

Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature
por: Ghisa, Matteo, et al.
Publicado: (2022)

Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
por: Savarino, Vincenzo, et al.
Publicado: (2021)

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy
por: Bagnasco, Diego, et al.
Publicado: (2023)

Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
por: Marasco, Giovanni, et al.
Publicado: (2023)

Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations
por: Ghisa, Matteo, et al.
Publicado: (2020)

Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak
por: Savarino, Edoardo Vincenzo, et al.
Publicado: (2020)

Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Clopidogrel-Induced Eosinophilic Colitis
por: Djahandideh Sheijani, Shirin, et al.
Publicado: (2023)

Prevention Strategies for Esophageal Cancer—An Expert Review
por: Marabotto, Elisa, et al.
Publicado: (2021)

Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Comparison of acid‐lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta‐Analysis
por: Barberio, Brigida, et al.
Publicado: (2022)

Quality-of-Life Evaluation in Coeliac Patients on a Gluten-Free Diet
por: Marsilio, Ilaria, et al.
Publicado: (2020)

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
por: Zingone, Fabiana, et al.
Publicado: (2020)

Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre
por: Zingone, Fabiana, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis and GERD: links and risks
por: Ghisa, Matteo, et al.
Publicado: (2019)

Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients
por: Savarino, Edoardo, et al.
Publicado: (2015)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Relevance of Measuring Substances in Bronchoalveolar Lavage Fluid for Detecting Aspiration-associated Extraesophageal Reflux Disease
por: Savarino, Edoardo, et al.
Publicado: (2017)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Optimal management of constipation associated with irritable bowel syndrome
por: Furnari, Manuele, et al.
Publicado: (2015)

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders
por: de Bortoli, Nicola, et al.
Publicado: (2018)

Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review
por: Marabotto, Elisa, et al.
Publicado: (2022)

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
por: Barberio, Brigida, et al.
Publicado: (2021)

No need of transforming gastroenterology units to covid units at the time of SARS-COV2 infection - a single-center analysis from northern italy
por: Zingone, Fabiana, et al.
Publicado: (2020)

Systematic review with meta‐analysis: artificial intelligence in the diagnosis of oesophageal diseases
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients
por: Marinelli, Carla, et al.
Publicado: (2019)

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
por: Barberio, Brigida, et al.
Publicado: (2022)

Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease
por: Savarino, Edoardo, et al.
Publicado: (2014)

Refractory Gastroesophageal Reflux Disease: A Management Update
por: Rettura, Francesco, et al.
Publicado: (2021)

Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
por: Massano, Alessandro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_al7hmb0id331etb1vs89d0j3l8